Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients
British Journal of Dermatology2013Vol. 169(4), pp. 916–921
Citations Over TimeTop 13% of 2013 papers
Abstract
Methotrexate is a useful and well-tolerated therapy with considerable steroid-sparing effect in patients with pemphigus vulgaris. It may be considered a first-line adjuvant therapy in the treatment of this difficult disease.
Related Papers
- Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.(1977)
- → Immunosuppressants and Prednisone in Pemphigus Vulgaris(1977)99 cited
- → Successful Use of Cyclophosphamide and Prednisone for Initial Treatment of Pemphigus Vulgaris(1978)67 cited
- → Some Electron-Microscopic Aspects of Pemphigus erythematosus compared to those of Pemphigus vulgaris(1972)2 cited